E. I. Du Pont De Nemours And Company Patent Portfolio Statistics

tip_user1

E I Du Pont De Nemours And Company

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of E I Du Pont De Nemours And Company look like?

Assignee Art Units
Total Applications: 89 926,606
Granted Patents: 56 410,067
Grant Index 70.0% ↑ 69.8%
Abandoned/Rejected Applications: 24 (30.0%) 177,418 (30.2%)
In-Process Applications: 9 339,121
Average Grant Time: 2.48 Years ↓ 2.76 Years
Average Office Actions: 1.39 ↓ 1.7

Which Technology Area E I Du Pont De Nemours And Company is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
1623 Organic Chemistry 9
1662 Plants 7
1663 Plants 7
1637 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 6
1652 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes 4

How many patents are E I Du Pont De Nemours And Company filing every year?

Year Total Applications Predicted
2022 0* 701
2021 1* 625
2020 1 511
2019 18 18
2018 12 –
2017 19 –
2016 15 –
2015 8 –
2014 9 –
2013 3 –

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of E I Du Pont De Nemours And Company in USPTO?

Publication number: None
Application number: 16/625,778

Abstract:
–

Publication date: –
Applicant: E I Du Pont De Nemours And Company
Inventors: Feng Wei

Publication number: None
Application number: 17/602,448

Abstract:
–

Publication date: –
Applicant: E I Du Pont De Nemours And Company
Inventors: Chiaki Okui

Publication number: US20220178954A1
Application number: 17/437,122

Abstract:
Described herein are methods for stratifying Alzheimer's disease among male and female subjects by analyzing biomarker metabolites. In one aspect, the biomarker metabolite comprises one or more of PC ae C44:4, PC ac C44:5, or PA ae C44:6; or PC ac C44:4, PC ac C44:5, PC aa C32:1, PC aa C32:0, or PC ae C42:4.

Publication date: 2022-06-09
Applicant: E I Du Pont De Nemours And Company
Inventors: Gabi Kastenmller

How are E I Du Pont De Nemours And Company’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
16/625,778 Display Panel And Manufacturing Method Thereof Application Undergoing Preexam Processing – –
17/602,448 Method For Producing Fluoropolymer Powder Sent to Classification contractor – –
17/437,122 Stratification By Sex And Apoe Genotype Identifies Metabolic Heterogeneity In Alzheimers Disease Docketed New Case – Ready for Examination OPAP Central, Docket
17/605,171 Method For Determining Teaching Style, And Computer Storage Medium Docketed New Case – Ready for Examination OPAP Central, Docket
16/615,692 Sealant Structure And Method Of Fabricating Display Panel Docketed New Case – Ready for Examination OPAP Central, Docket